Evaluation of Group Lifestyle Balance DVD in Primary Care Practice

Not Applicable

Completed

Conditions: Metabolic Syndrome
Prediabetes

Registration Number: NCT00480779

Lead Sponsor: University of Pittsburgh

Brief Summary: The purpose of this study is to examine different methods of delivering the Group Lifestyle Balance (GLB) intervention (1). The GLB is a 12-week lifestyle change program based on the highly successful lifestyle program that was used in the Diabetes Prevention Program (DPP)(2). A DVD of the Group Lifestyle Program has been developed. Conditions called metabolic syndrome and pre-diabetes increase the risk of diabetes and heart disease. Recent research has shown that type 2 diabetes and metabolic syndrome may be prevented or delayed by making lifestyle changes. A primary care practice will enroll participants who will choose either the GLB-DVD intervention or face-to-face group delivery. Approximately 25 patients will be recruited in each group. It is not known if the GLB intervention delivered via DVD is similarly effective to face-to-face group delivery for people with metabolic syndrome or pre-diabetes. It is hoped that this research study will provide information to help answer that question.

Detailed Description: The Group Lifestyle Balance program is a 12-session lifestyle intervention with the same goals for weight loss and physical activity as the successful Diabetes Prevention Program (DPP) lifestyle intervention and has been evaluated in several settings. The DPSC collaborated with the US Air Force Center of Excellence for Medical Multimedia to create a DVD of the GLB. The GLB-DVD is a series of taped sessions of a staged group following a script that was developed to closely follow the program.

Effectiveness was assessed for the intervention delivered via DVD (GLB-DVD) as well as traditionally in a group setting (GLB-GROUP). For each delivery mode, pre- and 3 month post-intervention measures of weight and the achievement of the program goals were assessed. Secondary outcomes measured included assessment of components of the metabolic syndrome (NCEP ATP III) and HbA1c.

The prevention professionals in the practice and the Diabetes Prevention Support Center (DPSC) who provided support for the GLB-DVD and GLB-GROUP participants were health care professionals trained in delivery of the GLB by the DPSC faculty. Group delivery of the GLB was conducted via weekly in person, meetings delivered over 12-15 weeks. For GLB-DVD delivery, an overview of the GLB-DVD and materials was provided at commencement of the intervention. Participants were instructed to view one session/week. At the end of each month the participant was asked to return their DVD via postage-paid mail to the DPSC and the next sequential DVD was mailed to the participant. During GLB-DVD delivery, the DPSC prevention professional contacted the participant weekly via telephone to review weight, physical activity minutes, and questions/concerns regarding the program. Thus, participants in both GLB-GROUP and GLB-DVD were offered a total of 12 health care professional contacts. Participants in both intervention delivery modes received a GLB workbook, fat and calorie counter, pedometer, and self-monitoring books for tracking food intake and physical activity.

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 48

Inclusion Criteria

Not provided

Exclusion Criteria

Those patients age less than 18 years old will not be invited to be part of the study. In addition, patients with any of the following conditions are not eligible to take part in the study:
- Those with previous diabetes diagnosis
- Women who are currently (or within past 6-weeks) pregnant or lactating
- Any patient deemed by their physician not to be a candidate
- Any patient planning to leave the area before the end of the program
- Individuals that are not patients of the participating primary care practices

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Weight	Baseline and 3 months	The primary outcome for this study will be change in weight measured pre and post intervention.

Secondary Outcome Measures

Name	Time	Method
Change in Total Cholesterol	Baseline and 3 months	A secondary outcome for this study will be change in total cholesterol, measured pre and post intervention.
Change in HDL Cholesterol	Baseline and 3 months	A secondary outcome for this study will be change in HDL cholesterol, measured pre and post intervention.
Change in Waist Circumference	Baseline and 3 months	A secondary outcome for this study will be change in waist circumference, measured pre and post intervention.
Change in LDL Cholesterol	Baseline and 3 months	A secondary outcome for this study will be change in LDL cholesterol, measured pre and post intervention.
Change in Fasting Glucose	Baseline and 3 months	A secondary outcome for this study will be change in fasting glucose, measured pre and post intervention.
Change in Triglycerides	Baseline and 3 months	A secondary outcome for this study will be change in Triglyceride level, measured pre and post intervention.
Change in Hemoglobin A1C	Baseline and 3 months	A secondary outcome for this study will be change in HbA1c, measured pre and post intervention. The hemoglobin HbA1c test provides information regarding how well blood glucose (sugar) has been controlled for the previous 8-12 weeks..
Change in Systolic Blood Pressure	Baseline and 3 months	A secondary outcome for this study will be change in systolic blood pressure, measured pre and post intervention.
Change in Diastolic Blood Pressure	Baseline and 3 months	A secondary outcome for this study will be change in diastolic blood pressure, measured pre and post intervention.

Trial Locations

Locations (1): University of Pittsburgh
🇺🇸
Pittsburgh, Pennsylvania, United States
University of Pittsburgh
🇺🇸Pittsburgh, Pennsylvania, United States